Scandinavian Journal of Infectious Diseases · 2013 · 26 citations · 11 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAntibiotic ResistanceBacterial EpidemiologyBacterial InfectionsCarbapenem ResistanceClinical BacteriologyHealthcare-associated InfectionsAcinetobacter Baumannii InfectionAcinetobacter Baumannii ResistanceCarbapenem AntibioticsClonal PersistenceGenetic Determinants Of ResistanceInfection Risk FactorsKlebsiella Pneumoniae CarbapenemaseKlebsiella Pneumoniae Resistance
OBJECTIVES: This investigation was conducted to study co-colonization by carbapenem-resistant Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-Kp) and Acinetobacter baumannii (CRAB) in intensive care unit (ICU) patients in Palermo, Sicily, a geographic area where both organisms are endemic in the healthcare setting. Risk factors at admission and during ICU stay and outcomes were also evaluated. METHODS: All patients colonized by KPC-Kp, or CRAB, or both in 2 ICUs of a large general hospital during the period October 2011-March 2012 were enrolled. Demographics and clinical data were collected. Resistance determinants and clonality of the 2 organisms were characterized by molecular methods. RESULTS: Seventy-five of 391 patients (19.2%) proved to be colonized by KPC-Kp, CRAB, or both: 30 (40%) were co-colonized and 44 (58.7%) were mono-colonized by CRAB and 1 by KPC-Kp. Younger age, major trauma, and length of stay were positively associated with co-colonization. However, no significant differences were detected between co-colonized and non co-colonized patients in infection and ICU mortality rates and length of stay after the first isolation. Both organisms proved to be circulating in a clonal way. CONCLUSIONS: In our setting, co-colonization by KPC-Kp and CRAB disproportionately affected young trauma patients with those with a prolonged ICU stay.
11
Teresa Horan, Mary Andrus, Margaret A. Dudeck · American Journal of Infection Control · 2008 · 6.6K citations
Public Health, Infectious Disease Control, Infectious Diseases +16
Mitchell J. Schwaber, Shiri Klarfeld-Lidji, Shiri Navon‐Venezia et al. · Antimicrobial Agents and Chemotherapy · 2007 · 487 citations
Life Sciences, Infectious Diseases, Antimicrobial Resistance +16
Federico Pérez, Andrea Endimiani, Amy J. Ray et al. · Journal of Antimicrobial Chemotherapy · 2010 · 197 citations · Full text